首页 Shockwave Medical, Inc .(usSWAV)-基本信息

Shockwave Medical, Inc .(usSWAV)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:139.68

最高价:139.8

成交量:368682.0

昨收价:137.99

最低价:136.52

最新价:137.01

行情图标
概要信息

英文名称:Shockwave Medical, Inc .


简介:ShockWave Medical, Inc.成立于2009年6月17日,是一家专注于开发和商业化产品的医疗器械公司,旨在改变钙化心血管疾病的治疗方式


电话:1-510-2794262


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 持股信息
  • 领导人信息

ShockWave Medical公司的目标是通过其用于治疗钙化斑块的声压力波的差异化和专有的局部输送(公司将其称为血管内碎石术——intravascular lithotripsy,IVL),建立医疗器械治疗动脉粥样硬化性心血管疾病的新的护理标准。ShockWave Medical公司的IVL系统(IVL System)利用其IVL技术(IVL Technology)——一种微创、易于使用且安全的方法——可显着改善患者的治疗效果。ShockWave Medical的Shockwave M5 IVL导管(M5导管)于2018年4月获得欧盟CE认证,并于2018年7月被美国食品和药物管理局(FDA)批准用于IVL系统,用于治疗外周动脉疾病(PAD)。ShockWave Medical目前在欧洲销售的Shockwave C2 IVL导管(C2导管)于2018年6月通过CE认证,用于治疗冠状动脉疾病(CAD)的IVL System。此外,公司还正在开展多项产品和适应症的临床计划,如果成功,将使公司能够将其产品的商业化扩展到更多的地区以及更多的适应症上。重要的是,ShockWave Medical还正在进行C2导管的持续临床试验,旨在支持美国的上市前申请(PMA),以及Shonin在日本提交的CAD治疗方案。公司预计,这些正在进行的临床试验的最终数据将支持其C2导管产品2021年上半年在美国推出,并将于2021年下半年在日本上市。

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
J.P. Morgan Investment Management, Inc. 190156 0.68% -16867 -8.15% 2019-07-31
RA Capital Management, LLC 495608 1.77% 495608 -- 2019-03-31
Sectoral Asset Management Inc 849811 3.03% 849811 -- 2019-03-31
VHCP Management II, LLC 901256 3.22% 901256 -- 2019-03-31
Gilder Gagnon Howe & CO LLC 1332559 4.76% 1332559 -- 2019-03-31
Fidelity Management & Research Company 1441809 5.15% 43896 3.14% 2019-07-31
T. Rowe Price Associates, Inc. 1894776 6.76% 1894776 -- 2019-03-31
Fidelity Management and Research Company 3664711 13.08% 3664711 -- 2019-03-31
FMR Inc 3712811 13.25% 3712811 -- 2019-03-31
Fidelity Management Trust Co 328275 1.17% -- -- 2019-07-31
Deerfield Management Co 312146 1.11% 312146 -- 2019-03-31
Redmile Group, LLC 300000 1.07% 300000 -- 2019-03-31
Adage Capital Partners Gp LLC 200000 0.71% 200000 -- 2019-03-31
Morgan Stanley Investment Management, Inc. 208987 0.75% 208987 -- 2019-03-31
BlackRock Fund Advisors 221824 0.79% 11221 5.33% 2019-07-31
Morgan Stanley - Brokerage Accounts 232080 0.83% 232080 -- 2019-03-31
Lord, Abbett & Co LLC 237571 0.85% 237571 -- 2019-03-31
Citadel Advisors Llc 257617 0.92% 257617 -- 2019-03-31
Capital World Investors 300000 1.07% 300000 -- 2019-03-31
Vanguard Investments Australia Ltd 192695 0.69% 117900 157.63% 2019-07-31
Capital Research and Management Company 300000 1.07% 300000 -- 2019-06-30
Perceptive Advisors LLC 150000 0.54% 150000 -- 2019-03-31
PGIM Investments LLC 102692 0.37% -- -- 2019-05-31
Millennium Management LLC 72368 0.26% 72368 -- 2019-03-31
Wellington Management Company LLP 74305 0.27% 74305 -- 2019-03-31
Wells Fargo Funds Management LLC 78757 0.28% 11588 17.25% 2019-05-31
The Variable Annuity Life Insurance Company 94086 0.34% 94086 -- 2019-05-31
Bellevue Group AG 100000 0.36% 100000 -- 2019-03-31
Goldman Sachs Group Inc 126064 0.45% 126064 -- 2019-03-31
Alyeska Investment Group, L.P. 70212 0.25% 70212 -- 2019-03-31
AH Lisanti Capital Growth LLC 58110 0.21% 58110 -- 2019-03-31
Fidelity SelectCo, LLC 77000 0.28% 77000 -- 2019-04-30
Vanguard Group Inc 49857 0.19% 49857 -- 2019-04-30
T. Rowe Price 49700 0.18% 49700 -- 2019-04-30
Columbia Mgmt Investment Advisers, LLC 44029 0.16% 44029 -- 2019-04-30
DWS Investment Management Americas, Inc. 18242 0.07% 18242 -- 2019-04-30
JPMorgan Chase Bank 16028 0.06% 16028 -- 2019-04-30
K2/D&S Management Co., L.L.C. 10134 0.04% 10134 -- 2019-04-30
Deutsche Asset Management Investment GmbH 10001 0.04% 10001 -- 2019-04-30
SEB Investment Management AB 10000 0.04% 10000 -- 2019-04-30
Hartford Funds Management Company, LLC 9100 0.03% 9100 -- 2019-04-30
Lisanti Capital Growth, LLC 8650 0.03% 8650 -- 2019-04-30
JP Morgan Asset Management (UK) Ltd 8000 0.03% 8000 -- 2019-04-30
Vanguard 143 -- 143 -- 2019-04-30
Advantus Capital Management. 971 -- 971 -- 2019-04-30
MML Investment Advisers, LLC 1770 0.01% 1770 -- 2019-04-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
iShares Russell 2000 Growth ETF 61865 0.22% 1915 3.19% 2019-07-30
JPMorgan Small Cap Growth Fund 160874 0.57% -15291 -8.68% 2019-06-30
iShares Russell 2000 ETF 153985 0.55% 9303 6.43% 2019-07-30
American Funds SMALLCAP World Fund 150000 0.54% -150000 -50.00% 2019-06-30
Lord Abbett High Yield Fund 125197 0.45% -57666 -31.54% 2019-05-31
Fidelity 104000 0.37% -2200 -2.07% 2019-06-30
PGIM Jennison Health Sciences Fund 102692 0.37% -- -- 2019-06-30
Vanguard Small Cap Growth Index Fund 102587 0.37% 102587 -- 2019-06-30
T. Rowe Price Small-Cap Stock Fund 90560 0.32% -1700 -1.84% 2019-06-30
Vanguard Extended Market Index Fund 82290 0.29% 72989 784.74% 2019-06-30
T. Rowe Price New Horizons Trust 77545 0.28% 47286 156.27% 2019-06-30
T. Rowe Price Health Sciences Port 66216 0.24% -1 -- 2019-06-30
Vanguard Small Cap Index 177718 0.63% 108122 155.36% 2019-06-30
Vanguard Total Stock Market Index Fund 192695 0.69% 117900 157.63% 2019-06-30
Fidelity Growth Company Commingled Pool 297475 1.06% -- -- 2019-06-30
T. Rowe Price New Horizons Fund 322282 1.15% 79123 32.54% 2019-06-30
T. Rowe Price Health Sciences Fund 1199065 4.28% -3 -- 2019-06-30
Wells Fargo Emerging Growth Fund 56575 0.20% 67 0.12% 2019-05-31
Morgan Stanley Inst Inception Port 52085 0.19% 52085 -- 2019-03-31
T. Rowe Price Instl Small-Cap Stock Fund 46412 0.17% 46412 -- 2019-03-31
EQ/Morgan Stanley Small Cap Growth Port 40347 0.14% -- -- 2019-04-30
Fidelity Blue Chip Growth Cmmngld Pool 30800 0.11% 8837 40.24% 2019-04-30
SEB Nordamerikafond Sm 38943 0.14% 28943 289.43% 2019-04-30
VALIC Company I Health Sciences Fund 77274 0.28% 77274 -- 2019-03-31
Multi-Manager Small Cap Equity Strat Fd 29929 0.11% 29929 -- 2019-03-31
DWS Health and Wellness Fund 18242 0.07% 18242 -- 2019-03-31
Securian T. Rowe Price Sm Cap Stock SP 1 971 -- 971 -- 2019-03-31

Keith D. Dawkins Currently, Keith D. Dawkins holds the position of Chairman of InnovHeart Srl and Chief Medical Officer of Shockwave Medical, Inc. Dr. Dawkins is also on the board of Avicena LLC and JenaValve Technology, Inc. Dr. Dawkins previously held the position of Global Chief Medical Officer & Executive VP at Boston Scientific Corp. and President at British Cardiovascular Society. Keith D. Dawkins received an undergraduate degree from the University of London.
Frederic H. Moll Dr. Frederic H. Moll, MD, is Independent Director at BIOLASE, Inc., Independent Director at Intersect ENT, Inc., Chairman at Restoration Robotics, Inc., Senior Advisor at Kearny Venture Partners, Chairman & Chief Executive Officer at Auris Surgical Robotics, Inc., and Chairman at ShockWave Medical, Inc. He is on the Board of Directors at Reflexion Medical, Inc., BIOLASE, Inc., Intersect ENT, Inc., and Tibion Corp. Dr. Moll was previously employed as Independent Director by MAKO Surgical Corp., Co-Founder by INSPIRATION Medical GmbH, Vice President & Medical Director by Intuitive Surgical, Inc., Medical Director-Surgical Device Division by Guidant Corp., Co-Founder by Origin Medsystems, Inc., an Advisor by Catalyst Health Ventures, and Founder by EndoTherapeutics. He also served on the board at Hansen Medical, Inc., Aptus Endosystems, Inc., and Innovative Spinal Technologies, Inc. He received his undergraduate degree from the University of California, Berkeley, a graduate degree from Stanford University, and a doctorate degree from UW Medicine.
Laura A. Francis Ms. Laura A. Francis is an Independent Director at Shockwave Medical, Inc. and a COO, Chief Financial & Accounting Officer at SI-BONE, Inc. She is on the Board of Directors at Shockwave Medical, Inc. Ms. Francis was previously employed as a Chief Financial Officer by Auxogyn, Inc., a Chief Financial Officer, Treasurer & VP-Finance by Promega Corp., a Chief Financial Officer by Bruker BioSciences Corp., a Chief Financial Officer by Nutra-Park, Inc., a Chief Financial Officer by Hypercosm LLC, an Engagement Manager by McKinsey & Co., Inc., and an Audit Manager by Coopers & Lybrand LLP. She also served on the board at Stemina Biomarker Discovery, Inc. She received her undergraduate degree from the University of Wisconsin and an MBA from Stanford Graduate School of Business.
Jay T. Watkins Founder of Gynecare, Inc. (New Jersey) and Origin Medsystems, Inc., Jay T. Watkins is a businessperson who has been the head of 5 different companies and holds the position of Chairman for Reflexion Medical, Inc. and Chairman for C2 Therapeutics, Inc. He is also on the board of 7 other companies. In the past Mr. Watkins held the position of Consultant at McKinsey & Co., Inc., Managing Director at De Novo Ventures, Chairman at ReCor Medical, Inc., President for Guidant Compass Group, Principal at Microgenics Corp., President-Minimally Invasive Surgery Group at Guidant Corp. and Director at Gynecare, Inc. (New Jersey). Mr. Watkins received an MBA from Harvard University and an undergraduate degree from Stanford University.
Antoine Papiernik Currently, Antoine Papiernik is Chairman & Managing Partner at Sofinnova Partners SAS. Mr. Papiernik is also on the board of 12 other companies. Mr. Papiernik previously occupied the position of Investment Director at CDC Entreprises Innovation. He received an MBA from The Wharton School of the University of Pennsylvania.
Ray Larkin Ray Larkin is a businessperson who has been the head of 11 different companies. Currently, Mr. Larkin is Chairman of Shockwave Medical, Inc., Chairman for REVA Medical, Inc., Chairman at Align Technology, Inc., Venture Partner at Cutlass Capital LLC, Chairman at Novasys Medical, Inc. and Non-Executive Chairman for HeartWare Pty Ltd. Mr. Larkin is also Chairman at St. Mary's College of California and Principal at Group Outcome LLC and on the board of 5 other companies. In the past Ray Larkin held the position of Member-Executive Committee at Synecor LLC, Manager-National Sales at Bentley Laboratories LLC, Chairman & Chief Executive Officer for Eunoe, Inc., Chairman of HeartWare International, Inc., President & Chief Executive Officer of Nellcor Puritan Bennett, Inc., President & Chief Executive Officer at Nellcor, Inc., Principal at United States Marine Corps and President for Advanced Medical Technology Association. Mr. Larkin received an undergraduate degree from LaSalle University.
Douglas Evan Godshall Presently, Douglas Evan Godshall is President, Chief Executive Officer & Director at Shockwave Medical, Inc. He is also on the board of EyePoint Pharmaceuticals, Inc. and The Medical Device Manufacturers Association. In his past career Mr. Godshall occupied the position of President-Vascular Surgery at Boston Scientific Corp., President, Chief Executive Officer & Director at Heartware Pty Ltd., President & Chief Executive Officer for HeartWare, Inc. and President, CEO, Executive Director & MD at HeartWare International, Inc. He received an undergraduate degree from Lafayette College and an MBA from Northeastern University.
John Colin Cahill Mr. John C. Cahill is Vice President at Venrock Associates. He is on the Board of Directors at Reflexion Medical, Inc., 10X Genomics, Inc. and ShockWave Medical, Inc. Mr. Cahill also served on the board at Simpirica Spine, Inc. Colin previously observed on the boards of Achaogen (AKAO) and Ariosa Diagnostics (acquired by Roche). Mr. Cahill received his undergraduate degree from Stanford University, an M.S. in Biological Sciences at Stanford University and an MBA from Stanford Graduate School of Business.
Daniel Puckett Presently, Daniel Puckett occupies the position of Chief Financial officer & Secretary at Shockwave Medical, Inc. In his past career Mr. Puckett occupied the position of Principal at Viad Corp., Head-Senior Finance & Operations at Affymetrix, Inc., Chief Financial Officer at Ariosa Diagnostics, Inc., Chief Financial Officer at Counsyl, Inc., Principal at Oath, Inc., Principal at BHP Billiton Group Ltd., Principal at Forest Laboratories, Inc. and Executive Director at Cerexa, Inc. Mr. Puckett received an MBA from the University of San Francisco and an undergraduate degree from Washington State University.
Hajime Tada Currently, Hajime Tada occupies the position of General Counsel at Shockwave Medical, Inc. In his past career he occupied the position of Vice President & General Counsel of Agilent Technologies, Inc. He received an undergraduate degree from Yale University and a graduate degree from New York University School of Law.
W. Patrick Stephens Presently, W. Patrick Stephens occupies the position of Vice President-Research & Development for Shockwave Medical, Inc. In his past career he was Vice President-Research & Development for Endologix, Inc. and Vice President-Product Development at Trivascular Technologies, Inc. (a subsidiary of Endologix, Inc.). Mr. Stephens received a graduate degree from the University of Arizona and an undergraduate degree from The University of Colorado.
Beaux Alexander Presently, Beaux Alexander holds the position of Vice President-Clinical Affairs at Shockwave Medical, Inc. Mr. Alexander previously was Senior Director-Clinical Research at Medtronic Vascular, Inc. He received an undergraduate degree from The Ohio State University and an MBA from Georgia State University.
Robert Fletcher Currently, Robert Fletcher occupies the position of Vice President-Marketing at Shockwave Medical, Inc. Mr. Fletcher received an MBA from Kellogg School of Management and an undergraduate degree from the University of Florida.
Cathy Harnett Cathy Harnett is Director-Human Resources at Shockwave Medical, Inc.
Mike Maszy Currently, Mike Maszy occupies the position of Vice President-Operations at Shockwave Medical, Inc. In his past career Mr. Maszy was Vice President-Manufacturing at Endologix, Inc. and Vice President-Manufacturing at TriVascular, Inc. (a subsidiary of Endologix, Inc.). Mr. Maszy received an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree and a graduate degree from the University of Florida.
Rob Williamson Currently, Rob Williamson occupies the position of Vice President-Sales at Shockwave Medical, Inc. In his past career he occupied the position of Sales Director of ZOLL Medical Corp. He received an undergraduate degree from Auburn University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐